Status:

Do Not Prescribe (DNP)

Decision Date:

November 2022

Comments

Use in adults and adolescents aged ≥12 years for the treatment of bleeding episodes and for the prevention of bleeding in those undergoing surgery or invasive procedures. Await clinician request.

Do Not Prescribe (DNP) Drug Classifications

• 2: Have a lack of data on safety compared with standard therapy
• 3: Have known increase in risk of adverse events compared with standard therapy
• 5: Less cost-effective than current standard therapy

search again